SCHEMBL23878720

SCHEMBL23878720

c1ccc2c3c(sc2c1)-c1[nH]ccc1CC3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.36
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
PNMT P11086 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
RAB9A P51151 2/20 0.32
KDM4E B2RXH2 1/20 0.32
AURKA O14965 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
MAPK10 P53779 1/20 0.32
RIPK1 Q13546 1/20 0.32
PTK2B Q14289 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1393409 0.70 GPR3 (0.43) GPR3DRD2DRD1DRD4DRD5
SCHEMBL1393267 0.67 MAPT (0.43) GPR3DRD2DRD1DRD4DRD5
SCHEMBL1393265 0.67 MAPT (0.43) GPR3DRD2DRD1DRD4DRD5
SCHEMBL12013258 0.67 GPR3 (0.52) GPR3DRD2DRD1DRD4DRD5
SCHEMBL15506272 0.66 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL1393376 0.66 CDK1 (0.50) GPR3MEN1KMT2AHPGDKDM4E
SCHEMBL20402086 0.65 DRD2 (0.39) GPR3DRD2DRD1DRD4DRD5
SCHEMBL23878721 0.65 HSD17B10 (0.45) GPR3MEN1KMT2AALDH1A1MAPT
Ammonia Solution, Strong SCHEMBL15466738 0.64 DRD2 (0.50) GPR3DRD2DRD1DRD4DRD5
SCHEMBL15506359 0.64 L3MBTL1 (0.38) GPR3DRD2DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12185626-B2 Chemical compounds, optoelectronic elements comprising at least one new chemical compound, and use of new chemical compounds in an optoelectronic element HELIATEK GMBH (DE) 2024-12-31 US disclosed
EP-3890041-B1 NEW CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2024-12-04 EP disclosed
US-20230165146-A1 CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2023-05-25 US disclosed
US-20230165146-A1 CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2023-05-25 US disclosed
US-20230165146-A1 CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2023-05-25 US disclosed
WO-2021198388-A1 NEW CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2021-10-07 WO disclosed
WO-2021198388-A1 NEW CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT HELIATEK GMBH (DE) 2021-10-07 WO disclosed
EP-3890041-A1 NEW CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT Heliatek GmbH (DE) 2021-10-06 EP disclosed
EP-3890041-A1 NEW CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT Heliatek GmbH (DE) 2021-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165146-A1 CHEMICAL COMPOUNDS, OPTOELECTRONIC ELEMENTS COMPRISING AT LEAST ONE NEW CHEMICAL COMPOUND, AND USE OF NEW CHEMICAL COMPOUNDS IN AN OPTOELECTRONIC ELEMENT ETV6, ALK, CHRM3 GPR3 229/4885DRD2 204/4885DRD1 337/4885
US-12185626-B2 Chemical compounds, optoelectronic elements comprising at least one new chemical compound, and use of new chemical compounds in an optoelectronic element ETV6, ALK, CHRM3 GPR3 229/4885DRD2 204/4885DRD1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.